Skip to content

Medical-device intelligence

Corgenix, Inc.: FDA clearances and recalls

Research Corgenix, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

23 clearance records and 0 recall records in the covered releases, across 1 source company names and 7 product codes. Dated history runs from Dec 7, 1998 to Apr 4, 2008.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

23 matching records
Device / recordCompany in FDA recordSourceSource date
IGG ANTI-ATHEROX TEST KITK072032 · MSVCorgenix, Inc.510(k)Apr 4, 2008FDA decision date
ASPIRINWORKS TEST KIT (11-DEHYDRO THROMBOXANE B2), MODEL 12136K062025 · OBWCorgenix, Inc.510(k)May 29, 2007FDA decision date
RHIGENE HEP-ANA TEST SYSTEMK042680 · DHNCorgenix, Inc.510(k)Nov 19, 2004FDA decision date
REAADS VON WILLEBRAND FACTOR ACTIVITY TEST KIT, MODEL 10826K032139 · GGPCorgenix, Inc.510(k)Apr 5, 2004FDA decision date
REAADS DSDNA QUANTITATIVE TEST KIT, MODEL 022-001K034013 · LKJCorgenix, Inc.510(k)Jan 8, 2004FDA decision date
REAADS II ANTI-CARDIOLIPIN IGG SEMI-QUANTITATIVE TEST KIT, MODEL 11139K032868 · MIDCorgenix, Inc.510(k)Oct 14, 2003FDA decision date
REAADS IGM ANTI-B2GPI TEST KIT, MODEL 038-001K031208 · MSVCorgenix, Inc.510(k)Jul 7, 2003FDA decision date
MODIFICATION TO REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTATIVE TEST KITK024195 · MIDCorgenix, Inc.510(k)Jan 3, 2003FDA decision date
REEADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK024196 · MIDCorgenix, Inc.510(k)Jan 3, 2003FDA decision date
REAADS IGA ANTI-CARDIOLIPIN SEMI-QUANTITATIVE TEST KIT, MODEL 026-001K022990 · MIDCorgenix, Inc.510(k)Sep 25, 2002FDA decision date
REAADS ANTI-CARDIOLIPIN IGG/IGM SEMI-QUANTITATIVE TEST KIT, MODEL 023-001K022992 · MIDCorgenix, Inc.510(k)Sep 25, 2002FDA decision date
REAADS ANTI-BETA 2 GLYCOPROTEIN I IGM TEST KITK013077 · MSVCorgenix, Inc.510(k)Sep 28, 2001FDA decision date
REAADS ANTI-BETA 2 GLYCOPROTEIN I IGA TEST KITK013079 · MSVCorgenix, Inc.510(k)Sep 28, 2001FDA decision date
REAADS ANTI-BETA 2 GLYCOPROTEIN I IGG TEST KITK013080 · MSVCorgenix, Inc.510(k)Sep 28, 2001FDA decision date
REAADS ANTI-PHOSPHATIDYLSERINE IGA SEMI-QUANTITIVE TEST KITK013018 · MIDCorgenix, Inc.510(k)Sep 20, 2001FDA decision date
MODIFICATION TO: REAADS ANTI-PHOSPHATIDYLSERINE IGG/IGM SEMI-QUANTITATIVE TEST KITK012567 · MIDCorgenix, Inc.510(k)Aug 23, 2001FDA decision date
REAADS IGG ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KITK001352 · DHCCorgenix, Inc.510(k)Apr 9, 2001FDA decision date
REAADS IGM ANTI-PROTHROMBIN SEMI-QUANTITATIVE TEST KITK001398 · DHCCorgenix, Inc.510(k)Mar 30, 2001FDA decision date
REAADS IGA ANTI-PHOSPHATIDYLSERINE SEMI-QUANTITATIVE TEST KITK000920 · MIDCorgenix, Inc.510(k)Apr 26, 2000FDA decision date
REAADS IGA ANTI-B2GP 1 TEST KITK982434 · MSVCorgenix, Inc.510(k)Dec 22, 1998FDA decision date
REAADS MONOCLONAL FREE PROTEIN S ANTIGEN TEST KITK983914 · GGPCorgenix, Inc.510(k)Dec 22, 1998FDA decision date
REAADS IGG ANTI-B2GPI TEST KITK982391 · MSVCorgenix, Inc.510(k)Dec 7, 1998FDA decision date
REAADS IGM ANTI-B2GP1 TEST KITK982433 · MSVCorgenix, Inc.510(k)Dec 7, 1998FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗